Clinical Trial Biorepository And Archiving Solutions Market To Reach $8.98 By 2033

Clinical Trial Biorepository And Archiving Solutions Market Growth & Trends

The global clinical trial biorepository and archiving solutions market size is anticipated to reach USD 8.98 by 2033, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.53% from 2026 to 2033 This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

 Request a free sample copy or view the report summary: Clinical Trial Biorepository & Archiving Solutions Market Report

Clinical Trial Biorepository And Archiving Solutions Market Report Highlights

• In 2025, the biorepository services segment dominated the market, accounting for a revenue share of 68.10%. The segment growth can be attributed to the rise in R&D of advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, which require effective storage, distribution, and processing solutions.

• On the basis of the product segment, the market is segmented into preclinical products and clinical products. In 2025, the clinical products segment accounted for the largest revenue share of 63.40% in the clinical trial biorepository & archiving solutions market.

• On the basis of phase segment, the market is segmented to preclinical, phase I, phase II, phase III, and phase IV. The preclinical segment accounted for the largest revenue share in 2025. The segment growth can be growing emphasis on data integrity & transparency.

• North America clinical trial biorepository & archiving solutions market accounted for the largest share of 38.15% in 2025. The increase in the number of clinical trials and several market players in the region aiming to expand their existing services are further contributing to the growth of clinical trial biorepository & archiving solutions.

Clinical Trial Biorepository And Archiving Solutions Market Segmentation

Grand View Research has segmented the global clinical trial biorepository and archiving solutions market based on service, product, phase, trials/application and region.

 Clinical Trial Biorepository And Archiving Solutions Service Outlook (Revenue, USD Million, 2021 - 2033)

• Biorepository Services

  • Warehousing & storage

  • Transportation

  • Sample Processing

  • Others

• Archiving Solution Services

  • Database Indexing and Management

  • Scanning & Destruction

  • Others

Clinical Trial Biorepository And Archiving Solutions Product Outlook (Revenue, USD Million, 2021 - 2033)

• Preclinical Products

• Clinical Products

  • Human Tissue

  • Organs

  • Cell Therapy

    • Stem Cell Therapy

    • Other Cell Therapy

  • Other biospecimens

• Medical Device-Generated Digital Data

Clinical Trial Biorepository And Archiving Solutions Phase Outlook (Revenue, USD Million, 2021 - 2033)

• Preclinical

• Phase I

• Phase II

• Phase III

• Phase IV

Clinical Trial Biorepository And Archiving Solutions Trials/Application Outlook (Revenue, USD Million, 2021 - 2033)

• Drug / Biopharmaceutical Trials

  • Cell Therapy Trials

  • Gene Therapy Trials

  • Others

• Medical Device Trials

• Self-Administered / Decentralized Trials

• Others

Clinical Trial Biorepository And Archiving Solutions Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Oman

  • Qatar

List Of Key Players in the Clinical Trial Biorepository And Archiving Solutions Market

• Medpace

• American Type Culture Collection (ATCC)

• Cell&Co BioServices (Cryoport)

• Brooks Life Sciences (Azenta, Inc.)

• Patheon (Thermo Fisher Scientific, Inc.)

• Precision Medicine Group, LLC.

• Labcorp Drug Development

• Q2 Solutions

• LabConnect

• Charles River Laboratories